1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinomaovarian squamous cell carcinomaActive, not recruitingPhase 22026-02-05NCT05737199